Thermo Fisher Scientific Inc.
TMO
$512.69
$4.590.90%
NYSE
| 12/31/2025 | 09/27/2025 | 06/28/2025 | 03/29/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 7.32% | -0.86% | 4.52% | 13.48% | 12.27% |
| Total Depreciation and Amortization | -1.89% | -10.53% | -13.33% | -15.67% | -11.56% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 156.45% | 122.95% | -11.26% | 49.21% | 126.44% |
| Change in Net Operating Assets | -24.75% | -446.67% | -236.11% | -81.07% | -65.53% |
| Cash from Operations | 5.08% | 3.37% | -28.62% | -42.21% | -11.63% |
| Capital Expenditure | 3.13% | -48.53% | 2.33% | -4.32% | -18.52% |
| Sale of Property, Plant, and Equipment | 58.82% | -80.00% | -93.75% | 200.00% | 54.55% |
| Cash Acquisitions | -- | -28.90% | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 175.16% | 261.86% | -84.38% | 89.51% | 2,583.33% |
| Cash from Investing | 4,355.00% | -15.23% | -13.83% | 74.04% | 105.32% |
| Total Debt Issued | -- | -- | 100.00% | 135.68% | -100.00% |
| Total Debt Repaid | 48.60% | 46.07% | -- | -- | 33.90% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 96.30% | -- | -- | 33.33% | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -8.72% | -8.67% | -8.72% | -10.37% | -9.56% |
| Other Financing Activities | 635.29% | -105.97% | -220.00% | -58.72% | -221.43% |
| Cash from Financing | 196.18% | 46.89% | -761.74% | 94.40% | -156.72% |
| Foreign Exchange rate Adjustments | 97.80% | -142.86% | 2,173.33% | 68.18% | -2,830.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -100.00% | -- | -- |
| Net Change in Cash | 1,348.89% | -6.80% | -72.69% | 105.12% | -132.66% |